Akers Biosciences Inc (AKR)

 

Latest News

Issue of Equity

RNS Number: 1752D Akers Biosciences, Inc. 24 April 2017 April 24, 2017 This announcement contains inside information Akers Biosciences, Inc. Issue of Equity Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, has received further conversion notices from warrant holders ...

Holding(s) in Company

RNS Number: 1895C Akers Biosciences, Inc. 11 April 2017 April 11, 2017 Akers Biosciences, Inc. Holdings in Company Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, was notified on April 7, 2017 that Empery Asset Management, LP has a shareholding of 724,000 common sh...

Akers Bio revenues up 40%

Akers Biosciences' total revenues rose by 40% to $2,960,912 in the year to the end of December. Akers Bio said growth was d...

Final Results

RNS Number: 1288C Akers Biosciences, Inc. 11 April 2017 April 11, 2017 This announcement contains inside information Akers Biosciences, Inc. Financial Results for the Year Ended December 31, 2016 Sales of Flagship Rapid HIT Test +85% over prior year Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers", "Akers Bio" or the "Company"), a developer of...

All News

DateHeadlineSource
24-04-17Issue of EquityRNS
11-04-17Holding(s) in CompanyRNS
11-04-17Akers Bio revenues up 40%StockMarketWire
11-04-17Final ResultsRNS
10-04-17Notice of ResultsRNS
10-04-17Issue of EquityRNS
10-04-17Akers Bio marketing HIT rapid test in Puerto RicoStockMarketWire
10-04-17Heparin PF4 Rapid Test in Puerto RicoRNS
07-04-17Akers Bio warrants exercised StockMarketWire
06-04-17Issue of EquityRNS
04-04-17Issue of EquityRNS
31-03-17FTSE falls on miners, financials as Old Mutual suffersStockMarketWire
31-03-17Issue of EquityRNS
30-03-17Detailed Year-end Trading UpdateRNS
29-03-17Notice of ResultsRNS
28-03-17Initial Order for Rapid Cholesterol Self-testRNS
16-02-17Akers Bio granted US patent StockMarketWire
16-02-17US Patent for Akers Wellness Tests CartridgeRNS
01-02-17Akers Bio revenues up 66%StockMarketWire
01-02-17Trading UpdateRNS
13-01-17Akers Bio offering increased StockMarketWire
13-01-17Issue of EquityRNS
10-01-17Issue of EquityRNS
09-01-17Supplement to Form S-3 Registration StatementRNS
20-12-16Akers Bio resolutions passed at AGMStockMarketWire
19-12-16Result of AGMRNS
19-12-16Agreement with GNYHA for PIFA Heparin PF4 TestRNS
01-12-16US Distribution Agreement: Cholesterol Self-testRNS
28-11-16Akers Bio completes BreathScan DKA trial StockMarketWire
28-11-16Clinical Trial for BreathScan DKA CompletedRNS
14-11-16Notice of AGMRNS
14-11-16Akers Bio revenues up 262%StockMarketWire
14-11-16Akers Bio revenues up 262%StockMarketWire
14-11-163rd Quarter ResultsRNS
10-11-16Akers Bio schedules Q3 results StockMarketWire
10-11-16Akers Bio granted European patentStockMarketWire
10-11-16European Patent GrantedRNS
09-11-16Notice of Q3 ResultsRNS
25-10-16Filing of Form S-3 Registration StatementRNS
19-08-16Akers Bio settles dispute with ChubeWorkxStockMarketWire

RSS feeds

  • Editorial news feed for LSE:AKR Editorial
  • Regulatory news feed for LSE:AKR Regulatory